Related Experiment Videos

Amphotericin B induced ocular toxicity in cryptococcal meningitis

P K Li1, K N Lai

  • 1Department of Medicine, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin.

Insights

Acute visual loss occurred after a test dose of amphotericin B in a patient with cryptococcal meningitis. Amphotericin B may worsen optic nerve disease, suggesting it should be avoided in such cases.

Area of Science:

  • Neurology
  • Ophthalmology
  • Infectious Diseases

Background:

  • Cryptococcal meningitis is a serious fungal infection often affecting immunocompromised individuals.
  • Systemic lupus erythematosus (SLE) is an autoimmune disease that can increase susceptibility to infections.
  • Intravenous amphotericin B is a common antifungal agent used to treat invasive fungal infections.

Observation:

  • A patient with SLE and cryptococcal meningitis experienced sudden, acute visual loss.
  • Visual acuity was normal before the administration of a low-dose (1 mg) intravenous amphotericin B test dose.
  • The patient's meningitis later improved with miconazole and flucytosine therapy.

Findings:

  • The case suggests a potential link between amphotericin B administration and acute visual loss in patients with cryptococcal meningitis.
  • Optic nerve involvement may be a contraindication for amphotericin B treatment in this context.
  • Alternative antifungal treatments were effective in managing the meningitis.

Implications:

  • Clinicians should consider the risk of visual disturbances when using amphotericin B for cryptococcal meningitis.
  • Suspected optic nerve disease in patients with cryptococcal meningitis warrants careful consideration of alternative antifungal strategies.
  • This case highlights the importance of monitoring visual function during antifungal therapy for meningitis.

Related Concept Videos